TABLE 1.
Classification | BMI (kg/m2) | ||||
---|---|---|---|---|---|
International classification (WHO) [2] | Asian population (WHO) [2] | Asian Indian population (Consensus Statement for Asian Indians of the Metabolic and Obesity Summit) [3] | Japanese population (JASSO) [4] | Korean population (KSSO) [5] | |
Underweight | <18.5 | <18.5 | ‐ | <18.5 | <18.5 |
Normal range | ≥18.5 and <25.0 | ≥18.5 and <23.0 | ≥18.0 and <23.0 | ≥18.5 and <25.0 | 18.5‐22.9 |
Overweight | ≥25.0 and <30.0 | ≥23.0 and <27.5 | ≥23.0 and <25.0 | ‐ | 23.0‐24.9 |
Obesity | ≥30.0 | ≥27.5 | ≥25.0 | ‐ | ‐ |
Obesity class I | ≥30.0 and <35.0 | ‐ | ‐ | ≥25.0 and <30.0 | 25.0‐29.9 |
Obesity class II | ≥35.0 and <40.0 | ‐ | ‐ | ≥30.0 and <35.0 | 30.0‐34.9 |
Obesity class III | ≥40.0 | ‐ | ‐ | ≥35.0 and <40.0 | ≥35.0 |
Obesity class IV | ‐ | ‐ | ‐ | ≥40.0 | ‐ |
Classification | Waist circumference (cm) | ||||
International Diabetes Federation [ 6 ] Central obesity defined as BMI > 30.0; if BMI ≤30.0, then waist circumference should be assessed |
KSSO [ 5 ] Increased risk of comorbidity (T2D, hypertension, and dyslipidemia) according to abdominal obesity |
||||
Central obesity |
|
|
Abbreviations: JASSO, Japan Society for the Study of Obesity; KSSO, Korean Society for the Study of Obesity; T2D, type 2 diabetes; WHO, World Health Organization.
In the US, the Adult Treatment Panel III values (102 cm for men; 88 cm for women) are likely to continue to be used for clinical purposes.